179 related articles for article (PubMed ID: 35717836)
1. Elevated serum midkine levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients.
Ketenci S; Uygar Kalaycı M; Dündar B; Duranay R; Şükrü Aynacıoğlu A
Int Immunopharmacol; 2022 Sep; 110():108939. PubMed ID: 35717836
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications.
Su Z; Lv X; Liu Y; Zhang J; Guan J; Gai Z
Int Immunopharmacol; 2016 Oct; 39():246-250. PubMed ID: 27497193
[TBL] [Abstract][Full Text] [Related]
4. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
5. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
6. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
[TBL] [Abstract][Full Text] [Related]
7. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
8. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
9. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
10. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
11. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Darif D; Hammi I; Kihel A; El Idrissi Saik I; Guessous F; Akarid K
Microb Pathog; 2021 Apr; 153():104799. PubMed ID: 33609650
[TBL] [Abstract][Full Text] [Related]
12. Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections.
Luo J; Brakel A; Krizsan A; Ludwig T; Mötzing M; Volke D; Lakowa N; Grünewald T; Lehmann C; Wolf J; Borte S; Milkovska-Stamenova S; Gabert J; Fingas F; Scholz M; Hoffmann R
Virol J; 2022 Mar; 19(1):50. PubMed ID: 35305688
[TBL] [Abstract][Full Text] [Related]
13. Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis.
Gao X; Chan PK; Wong KC; Ng RW; Yeung AC; Lui GC; Ling L; Hui DS; Huang D; Wong CK
Front Immunol; 2023; 14():1111920. PubMed ID: 36798115
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone.
Lawal B; Kuo YC; Rachmawati Sumitra M; Wu ATH; Huang HS
Comput Biol Med; 2022 Sep; 148():105814. PubMed ID: 35841781
[TBL] [Abstract][Full Text] [Related]
15. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anti-severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease-19 pandemic.
Adler JM; Weber C; Wernike K; Michelitsch A; Friedrich K; Trimpert J; Beer M; Kohn B; Osterrieder K; Müller E
Zoonoses Public Health; 2022 Aug; 69(5):439-450. PubMed ID: 35238485
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
18. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
19. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.
Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA
Front Immunol; 2021; 12():693462. PubMed ID: 34691016
[TBL] [Abstract][Full Text] [Related]
20. A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays.
Wang Q; Du Q; Guo B; Mu D; Lu X; Ma Q; Guo Y; Fang L; Zhang B; Zhang G; Guo X
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32277023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
